Genetic newborn screening for rare diseases
Part of Genetic & congenital clinical trials.
This study tests a new way to screen newborns for rare genetic diseases using a blood sample. It aims to find treatable conditions early so that babies can get care sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be a newborn born in a participating hospital or birth center.
- Both parents or legal guardians must sign a consent form agreeing to the genetic screening.
- If your baby later shows symptoms of a genetic disease in the first 2 years, they may also have whole genome sequencing.
- The study is only for babies whose parents have signed the required consent forms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for a genetic (DNA) explanation for rare diseases when usual genetic testing hasn’t found an answer. It may help by re-analyzing prior results and comparing them with parents’ DNA to better pinpoint the cause.
This trial offers free genetic screening for rare diseases in newborns. It aims to find health conditions early so babies can get the right care sooner.
This research study tests a new way to screen newborns for hundreds of genetic diseases using a sample of their blood or saliva. It aims to find conditions early so your baby can get the right care sooner.
This study looks at using rapid DNA testing (genomics) in newborns and children who are very sick in the hospital (NICU or PICU). The goal is to see if finding a genetic cause early can help guide treatment and improve outcomes.
This study looks at using whole genome sequencing in newborns and families with ongoing pregnancies, including those conceived naturally or with fertility treatments. It aims to better understand and manage genetic disease risks early.
This study uses a two-step genetic test (fast whole-genome sequencing followed by RNA testing if needed) to find the cause of unexplained, life-threatening conditions in newborns. The goal is to get a precise diagnosis faster, which could guide better care for your baby.
Hear when a new Newborn Screening trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.